High Ki67 expression is an independent good prognostic marker in colorectal cancer

High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer

(2015) Arisa Nishimukai et al.   Clinical Breast Cancer

Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression

(2014) A. Satelli et al.   CLINICAL CANCER RESEARCH

Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray

(2014) M. S. Reimers et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Factors Affecting the Nuclear Localization of β-Catenin in Normal and Malignant Tissue

(2014) Rhys G. Morgan et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Correlations Between Prognosis and Regional Biomarker Profiles in Head and Neck Squamous Cell Carcinomas

(2014) Gabriella Szentkúti et al.   PATHOLOGY & ONCOLOGY RESEARCH

Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer

(2013) Yuji Toiyama et al.   CARCINOGENESIS

p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells

(2013) Nam Hee Kim et al.   CELL CYCLE

Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence

(2013) Takeshi Yamaguchi et al.   Diagnostic Pathology

Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver

(2011) Zhaohai Yang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling

(2011) N. H. Kim et al.   Science Signaling

The role of mutant p53 in human cancer

(2010) Amanda M Goh et al.   JOURNAL OF PATHOLOGY

Regulation of tissue- and stimulus-specific cell fate decisions by p53 in vivo

(2010) James G Jackson et al.   JOURNAL OF PATHOLOGY

S3 Guidelines for Colorectal Carcinoma

(2010) W. Schmiegel et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer

(2009) Frédérique Penault-Llorca et al.   JOURNAL OF CLINICAL ONCOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients

(2008) R. Stuart-Harris et al.   BREAST

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

(2008) Robin L. Jones et al.   BREAST CANCER RESEARCH AND TREATMENT